Neck-zapping device helps sleep-deprived soldiers think

Vagus nerve stimulation can produce the effects of coffee.

A handheld device that delivers vagus nerve stimulation was shown to combat fatigue and improve cognitive performance in a study involving sleep-deprived soldiers — suggesting it could be a viable alternative to the traditional cup of coffee.

Sleep deprivation: Not getting enough sleep can do more than just leave you feeling tired — it can also affect your mood, focus, and ability to think.

That can be a big problem for people whose jobs regularly require them to stay awake for long periods of time and who also need to be on top of their game while at work — particularly doctors or soldiers.

The challenge: To combat the effects of sleep deprivation, some people gulp pots of coffee or take chemical stimulants.

However, those can produce unwanted side effects, such as anxiety and headaches. They can also be addictive, and it’s possible to build a tolerance to them, meaning users need to ingest more of the substances to achieve the same effect.

Vagus nerve stimulation: The vagus nerves extend from the brain through the neck and into the abdomen.

Electrically stimulating a vagus nerve, either with implants or external devices, has been shown to help treat a host of health problems, including epilepsy, depression, and migraines. It’s also been linked to improved memory and cognitive function.

Long day: For a new study, researchers used a handheld device called the gammaCore to see what impact vagus nerve stimulation might have on sleep-deprived soldiers.

40 active-duty U.S. Air Force personnel participated in the trial. Twelve hours after waking up, they received either vagus nerve stimulation with the gammaCore device or sham stimulation with a placebo device. They then remained awake for a total of 34 hours.

Not only do they perform better, but they also perceive that they’re performing better.


Richard McKinley

At nine points during the trial, each soldier completed activities designed to test their alertness and ability to multitask. They also responded to questionnaires that measured their mood.

The results: The soldiers who used the gammaCore device performed better on the tasks and reported feeling less fatigue and more energy. The effects of the vagus nerve stimulation lasted for about 19 hours, and peaked 12 hours post-stimulation.

“It’s exciting to us that not only do they perform better, but they also perceive that they’re performing better and that they feel less tired,” co-author Richard McKinley told Scientific American.

Looking ahead: The trial’s sample size was small, and all of the participants were active-duty military personnel, who tend to be younger and healthier than the general population.

However, if the results hold up in larger, more diverse trials, vagus nerve stimulation could one day provide sleep-deprived people with an electrifying new way to stay alert.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at tips@freethink.com.

Related
The exciting research that may cure Parkinson’s 
GeneCode is developing a drug it hopes won’t just alleviate Parkinson’s symptoms but also protect and restore patient’s neural health.
What hybrid mouse/rat brains are showing us about the mind
Modified mice with hybrid brains that include rat neurons could one day lead to new breakthroughs in neuroscience.
How sensory gamma rhythm stimulation clears amyloid in Alzheimer’s mice
Study finds stimulating a brain rhythm with light and sound increases peptide release from interneurons, possibly slowing Alzheimer’s progression.
Brain implant for “artificial vision” is still working after 2 years
A new type of brain implant technology has given a man with total blindness a kind of “artificial vision.”
Why a neurodivergent team will be a golden asset in the AI workplace
Since AI is chained to linear reasoning, workplaces that embrace it will do well to have neurodivergent colleagues who reason more creatively.
Up Next
Alzheimer's drug aducanumab
Exit mobile version